NASDAQ
Amplia Therapeutics Limited (INNMF) has a revenue compound annual growth rate of 156.28% over 5 years and 62.04% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.